2010
Psychotropic Medications in Autism: Practical Considerations for Parents
Williamson ED, Martin A. Psychotropic Medications in Autism: Practical Considerations for Parents. Journal Of Autism And Developmental Disorders 2010, 42: 1249-1255. PMID: 21170674, DOI: 10.1007/s10803-010-1144-2.Peer-Reviewed Original ResearchCharacterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures
Busch SH, Frank RG, Martin A, Barry CL. Characterizing Declines in Pediatric Antidepressant Use After New Risk Disclosures. Medical Care Research And Review 2010, 68: 96-111. PMID: 20675349, PMCID: PMC2974787, DOI: 10.1177/1077558710374197.Peer-Reviewed Original ResearchConceptsAntidepressant usePediatric antidepressant useAntidepressant medication useNew treatment episodeNew safety informationRisk of suicidalityAntidepressant medicationMedication useTreatment patternsTreatment episodesHealth outcomesLatter groupChildrenSafety informationFamily characteristicsCollege-educated parentsExperienced declinesMedicationsAntidepressantsDeclineFindingsSuicidality
2009
An fMRI Study of the Effects of Psychostimulants on Default-Mode Processing During Stroop Task Performance in Youths With ADHD
Peterson BS, Potenza MN, Wang Z, Zhu H, Martin A, Marsh R, Plessen KJ, Yu S. An fMRI Study of the Effects of Psychostimulants on Default-Mode Processing During Stroop Task Performance in Youths With ADHD. American Journal Of Psychiatry 2009, 166: 1286-1294. PMID: 19755575, PMCID: PMC3289412, DOI: 10.1176/appi.ajp.2009.08050724.Peer-Reviewed Original ResearchConceptsVentral anterior cingulate cortexAnterior cingulate cortexEffects of psychostimulantsCingulate cortexComparison subjectsLateral prefrontal cortexPrefrontal cortexStimulant medicationDefault-mode activityFunctional MRI scansPosterior cingulate cortexVentral anterior cingulateDefault mode processingMedicationsMRI scansAnterior cingulateHealthy comparison youthNormal levelsCortexPsychostimulantsGreater activationFMRI studyGreater reductionLateral prefrontalBrain activity
2004
Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology
Blair J, Taggart B, Martin A. Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology. Journal Of Neural Transmission 2004, 111: 791-815. PMID: 15205999, DOI: 10.1007/s00702-004-0153-8.Peer-Reviewed Original ResearchConceptsPediatric psychopharmacologyQTc prolongationQTc intervalNumber of medicationsTricyclic antidepressant desipramineAdult patientsYounger patientsElectrocardiographic monitoringAlpha agonistsSafety profileDeadly arrhythmiasAntidepressant desipramineSudden deathAdverse effectsMost reportsPatientsPsychopharmacologyProlongationCurrent knowledgeChildrenReportGuidelinesAntipsychoticsMedicationsTorsades
2003
Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000
Martin A, Leslie D. Trends in Psychotropic Medication Costs for Children and Adolescents, 1997-2000. JAMA Pediatrics 2003, 157: 997-1004. PMID: 14557161, DOI: 10.1001/archpedi.157.10.997.Peer-Reviewed Original ResearchConceptsCostly medicationsSelective serotonin reuptake inhibitorsPsychotropic medication costsPsychotropic medication utilizationSerotonin reuptake inhibitorsWarrants further studyMental health outpatientsMedication utilizationAtypical antidepressantsAtypical antipsychoticsPharmacy claimsReuptake inhibitorsMedication costsPsychotropic drugsDrug categoriesMedicationsNational databaseDrugsOverall useFurther studiesChildrenPrescription pricesAntipsychoticsAntidepressantsOutpatientsTwo-Year Trends in the Use of Seclusion and Restraint Among Psychiatrically Hospitalized Youths
Donovan A, Plant R, Peller A, Siegel L, Martin A. Two-Year Trends in the Use of Seclusion and Restraint Among Psychiatrically Hospitalized Youths. Psychiatric Services 2003, 54: 987-993. PMID: 12851435, DOI: 10.1176/appi.ps.54.7.987.Peer-Reviewed Original ResearchConceptsUse of seclusionProportion of episodesModalities of treatmentUse of medicationsTwo-year prevalenceState psychiatric hospitalIncidents of seclusionTwo-year trendsRestraint incidentsClinical dataEmergency basisPatient injuryPsychiatric hospitalCumulative durationPerformance improvement programEthnic minority groupsFurther studiesEpisodesChildrenShort episodesPercentConcurrent increaseSeclusionTotal numberMedications
2000
The use of psychotropic medications in young children: the facts, the controversy, and the practice.
Stubbe DE, Martin A. The use of psychotropic medications in young children: the facts, the controversy, and the practice. Connecticut Medicine 2000, 64: 329-33. PMID: 10909194.Peer-Reviewed Original Research
1999
Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use
MARTIN A, SCAHILL L, KLIN A, VOLKMAR F. Higher-Functioning Pervasive Developmental Disorders: Rates and Patterns of Psychotropic Drug Use. Journal Of The American Academy Of Child & Adolescent Psychiatry 1999, 38: 923-931. PMID: 10405512, DOI: 10.1097/00004583-199907000-00024.Peer-Reviewed Original ResearchConceptsPsychotropic drug useHigher-functioning pervasive developmental disordersPervasive developmental disorderTarget symptomsDrug useMedication use patternsPsychotropic medication useDevelopmental disordersMedication history informationMore medicationsMedication useClinical presentationPsychiatric comorbidityClinical variablesPsychotropic agentsDrug classesClinical heterogeneityDisordersSymptomsSubjectsAsperger's disorderFull Scale IQComorbiditiesMedicationsAntidepressants